Urodelia

  • Urodelia
    • Our vision and values
    • Our history and Identity
    • Our team
    • Our partnerships
    • Our commitments
    • Oncology activities
    • Research with nanoparticles
  • Animal health
    • For pets
    • UROELIA’s immuno oncology
    • Immuno oncology : scientific publications
  • Human health
    • Research in oncology
  • Press
  • Investors
  • Contact
Facebook
  • En
    • Fr
by Urodelia on 9 June 2020

PAROLES D’EXPERTS: INTERVIEW OF URODELIA AND DAVID SAYAG, VETERINARIAN SPECIALISED IN ONCOLOGY

read more
by Urodelia on 20 May 2020

ACTIVITY RESTARTED, IN COMPLIANCE WITH GOVERNMENT MEASURES FOLLOWING THE SPREAD OF CORONAVIRUS

read more
by Urodelia on 16 March 2020

GOVERNMENT MEASURES TO LIMIT THE SPREAD OF THE CORONAVIRUS

read more
by Urodelia on 3 February 2020

THE MONEGASQUE BIENNIAL OF ONCOLOGY WELCOMED URODELIA DURING AN ORAL PRESENTATION

read more
by Urodelia on 3 February 2020

THE MONEGASQUE BIENNIAL OF ONCOLOGY WELCOMED URODELIA DURING AN ORAL PRESENTATION

read more
by Urodelia on 22 November 2019

LE JOURNAL DES ENTREPRISES DEVOTES AN ARTICLE TO URODELIA AND ITS ACTIVITIES IN ONCOLOGY

read more
by Urodelia on 22 October 2019

THE JOURNAL “LA SEMAINE VETERINAIRE” DEVOTES AN ARTICLE TO “NEW EVIDENCE OF THE EFFECTIVENESS OF SELF-VACCINATION AGAINST B LYMPHOMA”

read more
by Urodelia on 22 September 2019

THE JOURNAL “LA DEPECHE VETERINAIRE” CONSECRATES AN ARTICLE ON URODELIA’S IMMUNO-ONCOLOGY TREATMENT

read more
Urodelia is the subject of an article in Biotech Finances (issue 861). Indeed, its Business Development in Animal Health partnership with 4P-Pharma represents a new phase in its deployment. 4P-Pharma, a French biotechnology company specializing in the development of drugs for humans and animals, will identify strategic opportunities in animal health for the licensing of ∞
Posted on 24 June 2019 by Urodelia in
esvonc-logo
by Urodelia on 22 May 2019

CONGRES ESVONC, GERMANY, 23-25 MAY 2019

read more

Pages:

1 2 »
Urodelia © 2019.
  • Facebook